Diabetes Crisis in South Africa: Prevalence, Impact, and Solutions

By Crystal Lubbe

November 19, 2024

In the article titled “Diabetes: A Pressing Public Health Challenge in South Africa,” the authors discuss the alarming rise of diabetes as a leading cause of death and morbidity in the country. They emphasise the urgent need for evidence-based strategies and strong leadership to address the impact of diabetes crisis in South Africa.

Prevalence and Impact of Diabetes in South Africa

Diabetes in South Africa is a significant health issue, affecting approximately 12% of the adult population, which translates to around 4.2 million individuals. This chronic condition is the second leading cause of death in the country, just after tuberculosis, and remains the leading cause of death among women. The prevalence of diabetes, particularly type 2 diabetes—accounting for more than 90% of cases—is on the rise due to changing diets that feature more processed foods, sugary drinks, and high-calorie meals. Furthermore, a lack of physical activity and increasing obesity levels contribute to this growing problem.

Diabetes Economic and Health Burden

The financial burden of diabetes in South Africa is staggering. The direct cost to the health system is estimated at R2.7 billion (approximately US$150 million) annually. If all cases were diagnosed and treated, this figure could skyrocket to R35 billion (US$1.9 billion) by 2030. Beyond the direct medical costs, the economic repercussions are profound. An estimate suggests that type 2 diabetes could incur losses of up to US$223 billion in productivity-adjusted life years (PALYs). Poorly managed diabetes can lead to severe complications, including nerve damage, kidney issues, heart disease, and vision impairment, which further burden both the healthcare system and the economy.

Global Impact of Diabetes

Diabetes is not just a local issue; it is a global health problem. Non-communicable diseases (NCDs) are responsible for 71% of deaths worldwide, with a disproportionate share of these occurring in low and middle-income countries. According to the World Health Organization (WHO), strategies such as advocating for healthy diets and increased physical activity can mitigate the impact of NCDs, including diabetes. One notable recommendation is to implement a higher tax on sugary beverages to reduce consumption and, consequently, the incidence of diabetes.

Challenges in Diabetes Management

In South Africa, a significant challenge in managing diabetes is the late diagnosis and inadequate treatment of the disease. Many individuals remain undiagnosed, while those who are identified often receive insufficient care, resulting in prolonged periods of hyperglycaemia and associated complications. Factors such as clinical inertia among healthcare providers, limited treatment options, and an under-resourced healthcare system hinder effective diabetes management.

Recommendations and Solutions

To combat diabetes in South Africa effectively, increasing the Health Promotion Levy on sugary beverages to 20% is advisable. This strategy aims to reduce sugar consumption and generate additional funds for public health initiatives. Enhancing early detection and treatment, improving the quality of primary care, and establishing dedicated surveillance systems for diabetes are crucial steps in managing the disease. Further investment in diabetes prevention and care, potentially through avenues like the Global Fund and the Health Promotion Levy, is necessary to relieve the healthcare system’s burden.

In summary, diabetes in South Africa is a critical public health challenge with far-reaching economic and health implications. It mirrors the global trend of rising NCDs, especially in low and middle-income countries. Addressing this pressing issue requires evidence-based policies, improved healthcare delivery, and decisive leadership to implement preventative measures and enhance treatment outcomes. By focusing on diabetes prevention and management, we can work towards a healthier South African population.

Reference url

Recent Posts

Collaboration Cardiac Surgery: Boosting Surgical Volumes Through Multidisciplinary Teams

By João L. Carapinha

September 1, 2025

Cardiovascular Business recently examines how closer collaboration cardiac surgery between interventional cardiologists and cardiac surgeons can increase patient referrals for surgical interventions. This is especially important as less-invasive procedures like transcatheter interventions grow in...
Innovative Strategies of MoonLake Immunotherapeutics HS in Targeting Inflammatory Diseases

By João L. Carapinha

August 30, 2025

MoonLake Immunotherapeutics HS, under the leadership of CEO Jorge Santos da Silva, is reimagining traditional biotech strategies with a concentrated approach to immunotherapeutic drug development. Utilizing innovative nanobody technology, the company is making strides in treating inflammatory dis...
TAVI Cost-Effectiveness in Brazil: Balancing Coverage Expansion and Economic Viability

By Staff Writer

August 21, 2025

The focus on TAVI cost-effectiveness Brazil has gained attention. The country is assessing the expansion of coverage for transcatheter aortic valve implantation (TAVI). This would include patients with severe aortic stenosis who are classified as low surgical risk (STS-PROM <4%) as a first-lin...